Mitch Raponi
About Mitch Raponi
Mitch Raponi is the Vice President of Translational Research and Biomarkers at BeiGene, with over two decades of experience in the biotechnology and pharmaceutical industries.
Current Position at BeiGene
Mitch Raponi serves as Vice President of Translational Research and Biomarkers at BeiGene. He has been with BeiGene since March 2017, where he leverages his extensive experience in the field to drive innovative research in biomarkers.
Previous Experience at Clovis Oncology
From 2010 to 2017, Mitch Raponi was Vice President of Molecular Diagnostics at Clovis Oncology in San Francisco, California, United States. During his seven-year tenure, he focused on advancing the company’s molecular diagnostics capabilities.
Experience at Centocor and Johnson & Johnson
In 2008, Mitch Raponi worked as a Principal Research Scientist at Centocor for five months. Subsequently, he joined Johnson & Johnson, where he served as Director of Oncology Biomarkers from 2008 to 2010. Prior to this, he was a Senior Scientist and Post-Doctoral Scientist at Veridex from 2001 to 2005.
Educational Background
Mitch Raponi studied at the University of New South Wales (UNSW), achieving a Bachelor of Science degree from 1991 to 1995. He continued his education at UNSW from 1997 to 2000.
Early Career and Roles
Mitch Raponi began his career as a Research Assistant at Johnson & Johnson from 1995 to 1997. He then took on research and managerial roles at Ortho Clinical Diagnostics and Veridex, gaining valuable experience in various capacities.